CJC-1295 with DAC

Each batch released by Vertex Labs is supported by batch-level documentation and Certificate of Analysis availability following quality review. Documentation may include identity confirmation, purity assessment, active weight verification, labeling review, and other analytical information relevant to the specific research batch.

Review available batch documentation through the
Vertex Labs COA database.
Additional information regarding laboratory review procedures, documentation standards, and quality controls is available on our
Testing Standards page.

CJC-1295 with DAC should be handled using established laboratory practices and appropriate internal quality procedures. Personnel should review the product label, batch-specific documentation, container condition, and applicable storage requirements before use in a controlled laboratory environment.

Keep the vial sealed until required for laboratory preparation and store the material according to the conditions specified on the product label. Laboratories should maintain appropriate handling, documentation, and material-control procedures for their research environment.

CJC-1295 with DAC is identified by its modified peptide structure and incorporated Drug Affinity Complex. This modification distinguishes it from CJC-1295 variants without DAC and is an important part of accurate material identification when documenting research compounds within laboratory workflows.

Researchers should verify the compound name, fill amount, batch information, and associated analytical documentation before use. Maintaining clear material identification and traceability helps support consistency across controlled research procedures and individual laboratory batches.

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Malimide-beta-Ala)-NH2